ArticleAdvances in therapy2021

Economic Benefit from Improvements in Quality of Life with Upadacitinib: Comparisons with Tofacitinib and Methotrexate in Patients with Rheumatoid Arthritis.

Martin Bergman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.